The Global Infection Surveillance Solutions Market size is expected to reach $1.3 billion by 2029, rising at a market growth of 12.9% CAGR during the forecast period.
The goal of infection surveillance solutions is to accurately apply preventive actions by continuously monitoring and interpreting data related to health. Data from infection surveillance is used to assess and guard against the harm preventable infections can do to patients and healthcare professionals. Hand hygiene, injection safety, antimicrobial resistance, surgical site infections, and hospitals that are open both during and after emergencies are all impacted by infection prevention and control.
During the projected period, key factors driving market growth include increasing antibiotic resistance among bacteria and increasing usage of automation in healthcare settings. In addition, increased hospital stays result from increased surgical procedures performed globally. There will consequently be an increase in the number of patients who contract HAIs.
The demand for solutions for infection surveillance is also anticipated to increase as healthcare costs rise. The market has also been expanding as a result of advantageous government initiatives. Additionally, the ability of IT systems to process analytics has increased, and this, together with technological developments in IT systems, is assisting in the creation of analytical or infection surveillance solutions for use in the healthcare sector.
The use of algorithms with specialized data mining tools, electronic medical records, and completely automated HAI surveillance using clinical support-based information that aids in the detection of specific clinical words are some of these methods. The market for infection surveillance solutions is experiencing significant expansion due to several causes, including increased surgeries and government rules to avoid HAIs.
The COVID-19 pandemic outbreak was beneficial for the market for infection control surveillance solutions. The COVID-19 pandemic has put a strain on the global healthcare system and raised the chance of COVID-19 patients contracting a healthcare-associated infection. The overpopulation of healthcare facilities was caused by the exponential growth in COVID-positive patients and the fast-increasing rate of viral transmission. In addition, the increased awareness of infection control resulted in increased demand for infection surveillance solutions even during the post-pandemic period.
Infection Control and Epidemiology (APIC) aims to stop the rising number of HAIs. A concern to world health and development is antimicrobial resistance (AMR). According to the WHO, one of the top 10 worldwide public health hazards to humanity is AMR. WHO introduced the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015, integrating information from human AMR and drug use surveillance. To meet the demands of healthcare facilities, several market participants have come up with surveillance solutions for antimicrobial stewardship. In light of this, the infection surveillance solutions market is predicted to support the market growth.
In nations with rising economies like India, China, Brazil, Russia, and those in Latin America and Southeast Asia, there are likely to be significant potential prospects for the infection surveillance solutions market. This is because a significant amount of the world's population, with more than half living in India and China, is concentrated in these areas. The need for better healthcare services has grown in these nations due to rising per capita income, rising healthcare awareness, an increase in hospitals & clinics, and a large patient population. The manufacturing of medical devices in these nations is being pushed by the rise of new markets to embrace infection control technology, creating prospects for market expansion.
The high cost of interoperability and deployment makes it difficult and expensive to implement IT software solutions for healthcare organizations. Smaller healthcare businesses have more difficulty integrating internet access since it is difficult to set up different networks in healthcare contexts, there are few wireless possibilities, and rigorous security measures are required to prevent data breaches. In addition to this, infection surveillance software can be quite pricey. In addition, the construction of a bespoke interface for the integration of a device after sales involves additional validation and verification, which adds to the overall cost of ownership for healthcare providers. Smaller hospitals & healthcare groups are unable to pay these additional costs and hence do deploy the solutions. Due to this, the infection surveillance solutions market is predicted to witness slow growth.
By product & services, the infection surveillance solutions market is segmented into software and services. The services segment covered a substantial revenue share in the infection surveillance solutions market in 2022. This is because infection surveillance software needs ongoing product updates and technical assistance. Clients' (healthcare providers') need for access to the vendor company's technical knowledge base, assistance from its product support team, and the acquisition of application management skills are fuelling the expansion of the product support & maintenance services.
Under software, the infection surveillance solutions market is divided into on-premise software and web-based software. In 2022, the on-premise segment witnessed the largest revenue share in the infection surveillance solutions market. This is due to the necessity for safe access to healthcare IT systems as well as the need to reduce the danger of data breaches and outside attacks. As a result, many healthcare businesses favor on-premise software solutions to guarantee the security of their patient data. Reusing existing storage and server gear is an additional advantage, especially for businesses upgrading or migrating from one system to another.
By end-user, the infection surveillance solutions market is categorized into hospitals, long-term care facilities and others. In 2022, the hospital segment registered the maximum revenue share in the infection surveillance solutions market. Hospitals have adopted infection control goods and services due to the increasing frequency of HAIs and the associated financial burden on stakeholders. The market is also expanding due to the high patient volume and rising incidence of surgical site infections (SSIs).
| Report Attribute | Details |
|---|---|
| Market size value in 2022 | USD 572.5 Million |
| Market size forecast in 2029 | USD 1.3 Billion |
| Base Year | 2022 |
| Historical Period | 2019 to 2021 |
| Forecast Period | 2023 to 2029 |
| Revenue Growth Rate | CAGR of 12.9% from 2023 to 2029 |
| Number of Pages | 205 |
| Number of Table | 333 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling |
| Segments covered | Product & Services, End User, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Region wise, the infection surveillance solutions market is analyzed across North America, Europe, Asia Pacific and LAMEA. In 2022, the North America region led the infection surveillance solutions market by generating the highest revenue share. Due to factors like the widespread use of healthcare IT solutions to contain the rise in healthcare costs, rapid consolidation of healthcare providers, and the rising prevalence of HAIs in the US, the market in North America is seeing major changes. Another important aspect of North America's significant market share in infection surveillance solutions is the abundance of businesses in the region.
Free Valuable Insights: Global Infection Surveillance Solutions Market size to reach USD 1.3 Billion by 2029
The major strategies followed by the market participants are Partnerships and Acquisition. Based on the Analysis presented in the Cardinal matrix; Oracle Corporation is the forerunner in the Infection Surveillance Solutions Market. Companies such as Becton, Dickinson and Company, Wolters Kluwer N.V., and Baxter International, Inc. are some of the key innovators in the Infection Surveillance Solutions Market.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Oracle Corporation (Cerner Corporation), Wolters Kluwer N.V., BioMérieux S.A., Baxter International, Inc., Harris Healthcare (Constellation Software, Inc.), Securitas AB, OSI Systems, Inc. (Spacelabs Healthcare), Gojo Industries, Inc. and Merative L.P. (Francisco Partners)
By Product & Services
By End User
By Geography
The Market size is projected to reach USD 1.3 billion by 2029.
Significant growth opportunities in emerging markets are driving the Market in coming years, however, Cost of deployment is unaffordable for small organizations restraints the growth of the Market.
Becton, Dickinson and Company, Oracle Corporation (Cerner Corporation), Wolters Kluwer N.V., BioMérieux S.A., Baxter International, Inc., Harris Healthcare (Constellation Software, Inc.), Securitas AB, OSI Systems, Inc. (Spacelabs Healthcare), Gojo Industries, Inc. and Merative L.P. (Francisco Partners)
The expected CAGR of this Market is 12.9% from 2023 to 2029.
The Software market is leading the segment in the Global Infection Surveillance Solutions Market by Product & Services in 2022; thereby, achieving a market value of $880.1 Million by 2029.
The North America market dominated the Market by Region in 2022; thereby, achieving a market value of $518.7 million by 2029.
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
